HomeCompareELOX vs ADC

ELOX vs ADC: Dividend Comparison 2026

ELOX yields 2475.25% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ELOX wins by $73382614261.60M in total portfolio value
10 years
ELOX
ELOX
● Live price
2475.25%
Share price
$0.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$73382614261.78M
Annual income
$67,980,042,160,694,380.00
Full ELOX calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — ELOX vs ADC

📍 ELOX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodELOXADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ELOX + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ELOX pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELOX
Annual income on $10K today (after 15% tax)
$210,396.04/yr
After 10yr DRIP, annual income (after tax)
$57,783,035,836,590,220.00/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, ELOX beats the other by $57,783,035,836,521,544.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELOX + ADC for your $10,000?

ELOX: 50%ADC: 50%
100% ADC50/50100% ELOX
Portfolio after 10yr
$36691307130.98M
Annual income
$33,990,021,080,387,590.00/yr
Blended yield
92.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

ELOX
Analyst Ratings
8
Buy
3
Hold
Consensus: Buy
Altman Z
-94.4
Piotroski
2/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELOX buys
0
ADC buys
0
No recent congressional trades found for ELOX or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricELOXADC
Forward yield2475.25%4.13%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$73382614261.78M$178.9K
Annual income after 10y$67,980,042,160,694,380.00$80,797.29
Total dividends collected$73004868605.64M$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: ELOX vs ADC ($10,000, DRIP)

YearELOX PortfolioELOX Income/yrADC PortfolioADC Income/yrGap
1← crossover$258,225$247,524.75$10,990$580.36+$247.2KELOX
2$6,249,854$5,973,553.08$12,301$860.26+$6.24MELOX
3$141,807,743$135,120,399.71$14,104$1,298.62+$141.79MELOX
4$3,017,015,462$2,865,281,177.24$16,691$2,008.16+$3017.00MELOX
5$60,200,153,348$56,971,946,803.11$20,580$3,205.09+$60200.13MELOX
6$1,126,836,870,511$1,062,422,706,429.18$26,754$5,330.02+$1126836.84MELOX
7$19,791,333,921,123$18,585,618,469,676.22$37,196$9,345.14+$19791333.88MELOX
8$326,252,175,090,930$305,075,447,795,328.50$56,244$17,523.09+$326252175.03MELOX
9$5,049,132,804,749,982$4,700,042,977,402,686.00$94,286$35,736.21+$5049132804.66MELOX
10$73,382,614,261,776,860$67,980,042,160,694,380.00$178,949$80,797.29+$73382614261.60MELOX

ELOX vs ADC: Complete Analysis 2026

ELOXStock

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.

Full ELOX Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this ELOX vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELOX vs SCHDELOX vs JEPIELOX vs OELOX vs KOELOX vs MAINELOX vs NNNELOX vs EPRTELOX vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.